TrialBMC cancer2014

VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Thomas Thomaidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.